CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 1.286
+0.011 (0.82%)
Jul 28, 2026, 8:00 AM GMT
CelLBxHealth Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -12.35 | -19.41 | -15.03 | -21.63 | -24.44 | -17.36 |
Depreciation & Amortization | 5.46 | 5.62 | 1.7 | 2.31 | 2.84 | 1.49 |
Stock-Based Compensation | -1.18 | -0.75 | 1.45 | 1.89 | 4.39 | 1.33 |
Other Adjustments | -1.86 | 0.84 | -0.44 | 1.14 | -1.67 | -0.04 |
Change in Receivables | 0.64 | 1.24 | -0.3 | -0.07 | -0.65 | 0.2 |
Changes in Inventories | 0.33 | 0.21 | 0.15 | 0.09 | -0.58 | -1.02 |
Changes in Accounts Payable | -0.75 | 0.08 | -0.59 | -1.01 | -0.98 | 1.42 |
Changes in Accrued Expenses | 0.36 | 0.52 | -0.4 | -0.04 | 0.59 | - |
Changes in Income Taxes Payable | 0.96 | 2.4 | - | 2.86 | 4.45 | -0.03 |
Operating Cash Flow | -8.66 | -9.26 | -13.45 | -14.46 | -16.05 | -14.01 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.16 | -0.22 | -0.41 | -0.61 | -1.72 | -1.67 |
Sale of Property, Plant & Equipment | 0 | - | - | 0 | - | - |
Purchases of Intangible Assets | 0.01 | -0.03 | -0.03 | -0.05 | -0.17 | -0.12 |
Other Investing Activities | 0.08 | 0.13 | 0.4 | 0.46 | 0.14 | 16.56 |
Investing Cash Flow | -0.07 | -0.12 | -0.05 | -0.2 | -1.75 | 14.77 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Issuance of Common Stock | 7.44 | 7.62 | 8.63 | 0.01 | 19.05 | 19.69 |
Repurchase of Common Stock | -0.03 | -0.03 | - | - | - | - |
Net Common Stock Issued (Repurchased) | 7.41 | 7.59 | 8.63 | 0.01 | 19.05 | 19.69 |
Other Financing Activities | -0.96 | -1.3 | -0.96 | -1.14 | -0.95 | -0.7 |
Financing Cash Flow | 6.45 | 6.29 | 7.67 | -1.13 | 18.1 | 18.99 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.1 | 0.02 | 0.04 | 0.11 | -0.24 | 0 |
Net Cash Flow | -2.29 | -3.1 | -5.83 | -15.79 | 0.3 | 19.76 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -8.83 | -9.48 | -13.86 | -15.07 | -17.77 | -15.68 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -766.06% | -701.63% | -484.24% | -689.34% | -1706.82% | -1547.48% |
Free Cash Flow Per Share | -0.01 | -0.03 | -0.05 | -0.06 | -0.07 | -0.07 |
Levered Free Cash Flow | -5.56 | -10.7 | -15.37 | -16.53 | -17.08 | -14.82 |
Unlevered Free Cash Flow | -5.45 | -10.54 | -15.44 | -19.66 | -22.33 | -19.37 |